Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
25.00
+9.00 (56.25%)
At close: Jul 31, 2026, 4:00 PM EDT
22.52
-2.48 (-9.92%)
After-hours: Jul 31, 2026, 7:57 PM EDT

Apnimed Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
120.1538.478.01-1
Revenue Growth
11915.00%380.12%---
Gross Profit
112.6131.774.64-1
Operating Income
41.34-53.82-114.23-48.52-26.55
Net Income
-31.83-128.19-111.31-80.25-26.21
Earnings Per Share
-6.28-23.76-20.73-27.84-11.04
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
46.8941.8968.35173.96133.83
Total Debt
39.3541.521.1-0.11
Net Cash (Debt)
7.540.3767.26173.96133.72
Net Cash Growth
-94.36%-99.45%-61.34%30.09%-
Net Cash Per Share
1.390.0712.5260.3556.31

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-69.19-77.83-110.2125.41-26.13
Capital Expenditures
---0.07-0.05-
Free Cash Flow
-69.19-77.83-110.2825.37-26.13
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
93.73%82.60%57.95%-100.00%
Operating Margin
34.41%-139.91%-1425.79%--2654.80%
Pretax Margin
32.46%-150.91%-1354.84%--2620.80%
Profit Margin
-26.49%-333.25%-1389.23%--2620.80%
FCF Margin
-57.59%-202.33%-1376.42%--2612.90%